Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.
Michel Eichelbaum, … , Johannes Zundler, Heyo K. Kroemer
Michel Eichelbaum, … , Johannes Zundler, Heyo K. Kroemer
Published August 15, 2002
Citation Information: J Clin Invest. 2002;110(4):571-571. https://doi.org/10.1172/JCI6663C1.
View: Text | PDF | Amended Article
Corrigendum

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.

  • Text
  • PDF
Abstract

Corrigendum

Authors

Michel Eichelbaum, Bernd Greiner, Peter Fritz, Hans-Peter Kreichgauer, Oliver von Richter, Johannes Zundler, Heyo K. Kroemer

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
(c) Correlation between AUC of orally administered digoxin (1 mg)
      ...
(c) Correlation between AUC of orally administered digoxin (1 mg) and expression of P-gp (n = 16) measured by Western blot. Open squares, without rifampin; filled squares, with rifampin (600 mg).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts